Format

Send to

Choose Destination
PLoS One. 2012;7(6):e38158. doi: 10.1371/journal.pone.0038158. Epub 2012 Jun 1.

New mutations in chronic lymphocytic leukemia identified by target enrichment and deep sequencing.

Author information

1
Molecular Pathology Programme, Spanish National Cancer Research Centre, CNIO, Madrid, Spain.

Abstract

Chronic lymphocytic leukemia (CLL) is a heterogeneous disease without a well-defined genetic alteration responsible for the onset of the disease. Several lines of evidence coincide in identifying stimulatory and growth signals delivered by B-cell receptor (BCR), and co-receptors together with NFkB pathway, as being the driving force in B-cell survival in CLL. However, the molecular mechanism responsible for this activation has not been identified. Based on the hypothesis that BCR activation may depend on somatic mutations of the BCR and related pathways we have performed a complete mutational screening of 301 selected genes associated with BCR signaling and related pathways using massive parallel sequencing technology in 10 CLL cases. Four mutated genes in coding regions (KRAS, SMARCA2, NFKBIE and PRKD3) have been confirmed by capillary sequencing. In conclusion, this study identifies new genes mutated in CLL, all of them in cases with progressive disease, and demonstrates that next-generation sequencing technologies applied to selected genes or pathways of interest are powerful tools for identifying novel mutational changes.

PMID:
22675518
PMCID:
PMC3365884
DOI:
10.1371/journal.pone.0038158
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center